BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Theilig D, Steffen I, Malinowski M, Stockmann M, Seehofer D, Pratschke J, Hamm B, Denecke T, Geisel D. Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI. Eur Radiol 2019;29:5861-72. [DOI: 10.1007/s00330-019-06101-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Cai S, Lin X, Sun Y, Lin Z, Wang X, Lin N, Zhao X. Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma. Eur J Radiol 2022;154:110449. [PMID: 35901599 DOI: 10.1016/j.ejrad.2022.110449] [Reference Citation Analysis]
2 Marasco G, Dajti E, Serenari M, Alemanni LV, Ravaioli F, Ravaioli M, Vestito A, Vara G, Festi D, Golfieri R, Cescon M, Renzulli M, Colecchia A. Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis. Cancers (Basel) 2022;14:1935. [PMID: 35454842 DOI: 10.3390/cancers14081935] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang Q, Kesen S, Liljeroth M, Nilsson H, Zhao Y, Sparrelid E, Brismar TB. Quantitative evaluation of liver function with gadoxetic acid enhanced MRI: Comparison among signal intensity-, T1-relaxometry-, and dynamic-hepatocyte-specific-contrast-enhanced MRI- derived parameters. Scand J Gastroenterol 2022;:1-8. [PMID: 35108168 DOI: 10.1080/00365521.2022.2032321] [Reference Citation Analysis]
4 Heise D, Schulze-Hagen M, Bednarsch J, Eickhoff R, Kroh A, Bruners P, Eickhoff SB, Brecheisen R, Ulmer F, Neumann UP. CT-Based Prediction of Liver Function and Post-PVE Hypertrophy Using an Artificial Neural Network. J Clin Med 2021;10:3079. [PMID: 34300246 DOI: 10.3390/jcm10143079] [Reference Citation Analysis]
5 Xu B, Li XL, Ye F, Zhu XD, Shen YH, Huang C, Zhou J, Fan J, Chen YJ, Sun HC. Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure. J Clin Transl Hepatol 2021;9:291-300. [PMID: 34221915 DOI: 10.14218/JCTH.2021.00013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Poetter-Lang S, Bastati N, Messner A, Kristic A, Herold A, Hodge JC, Ba-Ssalamah A. Quantification of liver function using gadoxetic acid-enhanced MRI. Abdom Radiol (NY) 2020;45:3532-44. [PMID: 33034671 DOI: 10.1007/s00261-020-02779-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Fahlenkamp UL, Ziegeler K, Adams LC, Böker SM, Engel G, Makowski MR. Intracellular accumulation capacity of gadoxetate: initial results for a novel biomarker of liver function. Sci Rep 2020;10:18104. [PMID: 33093649 DOI: 10.1038/s41598-020-75145-y] [Reference Citation Analysis]
8 Bae JS, Lee DH, Yoo J, Yi NJ, Lee KW, Suh KS, Kim H, Lee KB. Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection. Eur Radiol 2021;31:2461-71. [PMID: 33026503 DOI: 10.1007/s00330-020-07313-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Tsujita Y, Sofue K, Komatsu S, Yamaguchi T, Ueshima E, Ueno Y, Kanda T, Okada T, Nogami M, Yamaguchi M, Tsurusaki M, Hori M, Fukumoto T, Murakami T. Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion. Eur J Radiol 2020;130:109189. [PMID: 32784077 DOI: 10.1016/j.ejrad.2020.109189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Niekamp AS, Huang SY, Mahvash A, Odisio BC, Ahrar K, Tzeng CD, Vauthey JN. Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma. Eur Radiol 2020;30:3862-8. [PMID: 32144462 DOI: 10.1007/s00330-020-06746-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Bastati N, Beer L, Mandorfer M, Poetter-lang S, Tamandl D, Bican Y, Elmer MC, Einspieler H, Semmler G, Simbrunner B, Weber M, Hodge JC, Vernuccio F, Sirlin C, Reiberger T, Ba-ssalamah A. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid–enhanced MRI Predict Outcomes in Chronic Liver Disease? Radiology 2020;294:98-107. [DOI: 10.1148/radiol.2019190734] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
12 Theilig D, Elkilany A, Jann H, Roderburg C, Hamm B, Fehrenbach U, Geisel D. Evaluating hepatotoxic effects of chemotherapeutic agents with gadoxetic-acid-enhanced magnetic resonance imaging. Eur J Radiol 2020;124:108807. [PMID: 31926386 DOI: 10.1016/j.ejrad.2019.108807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]